Scarica l'app Stockscreener
10.90
2.33%
-0.26
Dopo l'orario di chiusura:
10.90
Precedente Chiudi:
$11.16
Aprire:
$11.06
Volume 24 ore:
202.50K
Relative Volume:
0.76
Capitalizzazione di mercato:
$545.01M
Reddito:
$62.02M
Utile/perdita netta:
$-45.65M
Rapporto P/E:
-11.85
EPS:
-0.92
Flusso di cassa netto:
$-9.60M
1 W Prestazione:
-1.18%
1M Prestazione:
-0.09%
6M Prestazione:
+16.20%
1 anno Prestazione:
+8.67%
Intervallo 1D:
$10.88
$11.06
Intervallo di 1 settimana:
$10.88
$11.26
Portata 52W:
$7.44
$11.88
Theravance Biopharma Inc Stock (TBPH) Company Profile
Nome
Theravance Biopharma Inc
Settore
Industria
Telefono
650-808-6000
Indirizzo
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Confronta TBPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TBPH
Theravance Biopharma Inc
|
10.90 | 558.01M | 62.02M | -45.65M | -9.60M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-06 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-04-12 | Iniziato | BTIG Research | Buy |
| 2024-01-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-05-23 | Iniziato | SVB Leerink | Outperform |
| 2021-11-05 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Downgrade | JP Morgan | Overweight → Underweight |
| 2021-08-25 | Downgrade | Morgan Stanley | Overweight → Underweight |
| 2021-08-24 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-10-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-07 | Iniziato | JP Morgan | Overweight |
| 2020-06-15 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-05-13 | Iniziato | Cowen | Outperform |
| 2020-01-08 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-06 | Aggiornamento | Robert W. Baird | Underperform → Neutral |
| 2019-10-29 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-29 | Ripresa | Piper Jaffray | Overweight |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-06-16 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-05-11 | Reiterato | Needham | Buy |
| 2016-12-21 | Iniziato | Needham | Buy |
| 2016-11-03 | Iniziato | Piper Jaffray | Overweight |
| 2016-10-12 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2016-08-03 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2016-06-20 | Iniziato | Guggenheim | Buy |
| 2016-06-20 | Reiterato | Leerink Partners | Outperform |
| 2016-05-12 | Iniziato | Leerink Partners | Outperform |
| 2016-05-05 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2015-02-03 | Aggiornamento | Robert W. Baird | Underperform → Neutral |
Mostra tutto
Theravance Biopharma Inc Borsa (TBPH) Ultime notizie
What is Theravance Biopharma Inc. company’s growth strategySwing Trade Forecasts For Smart Trading - jammulinksnews.com
Theravance Biopharma Inc. stock chart pattern explainedRisk Shielded Trade Watch with Analysis - Newser
Using RSI to spot recovery in Theravance Biopharma Inc.Free Pattern Breakout Entry Stock Forecast - Newser
Bank of New York Mellon Corp Boosts Stake in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Theravance Biopharma Inc.’s volatility index tracking explainedShort-Term Market Movement Forecast Report - Newser
Using Ichimoku Cloud for Theravance Biopharma Inc. technicalsFree Low Capital High Return Stock Plans - Newser
What earnings revisions data tells us about Theravance Biopharma Inc.Free Early Breakout Entry Point Notifications - Newser
Should I hold or sell Theravance Biopharma Inc. stock in 2025Real Time Signals For Consistent Profits - jammulinksnews.com
Is Theravance Biopharma Inc. stock a good hedge against inflationConservative Asset Allocation Risk Analysis - Newser
What is the risk reward ratio of investing in Theravance Biopharma Inc. stockBreakout Stocks Updates With Proven Results - jammulinksnews.com
What’s the recovery path for long term holders of Theravance Biopharma Inc.Early Breakout Entry Point Notifications Sent - metal.it
Applying Wyckoff theory to Theravance Biopharma Inc. stockFree Triple Digit Return Stock Predictions - Newser
How Theravance Biopharma Inc. stock performs during market volatilityValue Holding Return Summary With Outlook - Newser
How to use a screener to detect Theravance Biopharma Inc. breakoutsFree Stable Entry High Return Opportunities - Newser
Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Bought by GSA Capital Partners LLP - Defense World
What makes Theravance Biopharma Inc. stock price move sharplyPattern Breakout Tracker with Screener Tools - Newser
Theravance Biopharma Inc. Stock Performance After Earnings: Historical InsightsFuture Growth Stock Forecasting Strategy - Newser
What institutional flow reveals about Theravance Biopharma Inc.Trade Flow Monitor with Volume Tracker - Newser
How strong is Theravance Biopharma Inc. company’s balance sheetBest Dividend Report For Fast Growth - jammulinksnews.com
How does Theravance Biopharma Inc. compare to its industry peersSwing Trade Review With Proven Results - jammulinksnews.com
What are analysts’ price targets for Theravance Biopharma Inc. in the next 12 monthsRapid market gains - jammulinksnews.com
Theravance Biopharma to Report Second Quarter 2025 Financial Results on August 12, 2025 - Lelezard
Theravance Biopharma Sets Q2 Earnings Date: Key Financial Results Coming August 12 After Market Close - Stock Titan
What institutional flow reveals about Theravance Biopharma Inc. 3-Day Market Movement Forecast Analysis - Newser
Applying Wyckoff theory to Theravance Biopharma Inc. stock Free Reliable Investment Entry Point Signals - Newser
Applying Wyckoff theory to Theravance Biopharma Inc. stock Investment Timeline and ROI Summary Report - Newser
How many analysts rate Theravance Biopharma Inc. as a “Buy”Achieve rapid returns with smart investment plans - jammulinksnews.com
Is Theravance Biopharma Inc. stock overvalued or undervaluedInvest confidently with data-driven strategies - jammulinksnews.com
What are the technical indicators suggesting about Theravance Biopharma Inc.Get expert analysis on top stock picks - jammulinksnews.com
What are the latest earnings results for Theravance Biopharma Inc.Consistent high-performance stocks - jammulinksnews.com
Moving Average Trends for Theravance Biopharma Inc. Stock: What They IndicateDaily Stock Watch Summary with Key Insights - Newser
Why Theravance Biopharma Inc. stock attracts strong analyst attentionEntry Level Low Risk Picks - Newser
Theravance Biopharma Inc. Stock Analysis and ForecastOutstanding capital appreciation - PrintWeekIndia
Is Theravance Biopharma Inc. a good long term investmentFree Predictions - Autocar Professional
Theravance Biopharma Inc Azioni (TBPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):